An algorithm developed by scientists at UC San Francisco and UC Berkeley did better than two out of four expert radiologists at finding tiny brain hemorrhages in head scans—an advance that one day may help doctors treat patients with TBI, strokes and aneurysms.
Research team has detected the immunological remnants of a common seasonal virus in spinal fluid from dozens of patients diagnosed with acute flaccid myelitis (AFM). The findings provide the clearest evidence to date that AFM is caused by an enterovirus (EV) that invades and impairs the central nervous system.
Four UCSF faculty members are among the 10 new members and 10 international members elected this year to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
The UCSF scientists who identified the two known human genes that promote “natural short sleep” have now discovered a third, and it’s also the first gene that’s ever been shown to prevent the memory deficits that normally accompany sleep deprivation.
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and UC San Francisco, to advance treatments for frontotemporal lobar degeneration.
Scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia, adding to growing evidence that the loss of brain cells associated with dementia spreads via the synaptic connections between established brain networks.
Chancellor Sam Hawgood will deliver his sixth State of the University address, reflecting on the extraordinary confluence of science and technology in the Bay Area that is generating unprecedented advances in biomedical science and the development of new therapies.
The UCSF School of Nursing has unveiled a new mural that commemorates a diverse set of nurse heroes whose work and advocacy revolutionized health care and paved the way for diversity and inclusion in nursing.
International team of researchers report progress in using stem cells to develop new therapies for Pelizaeus-Merzbacher disease, a rare genetic condition affecting boys that can be fatal before 10 years of age.